Viewing Study NCT06815003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-06-27 @ 11:09 PM
Study NCT ID: NCT06815003
Status: RECRUITING
Last Update Posted: 2025-06-27
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Acute Myeloid Leukemia View
None Chronic Myelomonocytic Leukemia View
None Graft Versus Host Disease View
None Myelodysplastic Syndrome View
None Myeloproliferative Neoplasm View
Keywords: